SER-109
Seres Therapeutics
['$mcrb']
$mcrb and nestl present results from ecospor iv phase 3 study of vowst a microbiota-based oral therapeutic for prevention of recurrence of c. difficile infection, at #ddw2023 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind.